The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6818809 7406355 F 1 6818809-3 20090701 20100622 20100630 EXP 2010EU001937 ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. 59 YR M N 105 KG 20100629 OT UNITED KINGDOM

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6818809 1014042638 PS SOLIFENACIN SUCCINATE (VESICARE) 1 ORAL ORAL D 21518
6818809 1014106288 C BISOPROLOL FUMARATE 1
6818809 1014106290 C LANSOPRAZOLE 1
6818809 1014106292 C PERINDOPRIL ERBUMINE 1
6818809 1014106293 C RAMIPRIL 1
6818809 1014106294 C SIMVASTATIN 1
6818809 1014106295 C WARFARIN SODIUM 1
6818809 1014106296 C TAMSULOSIN HCL 1

Indications of drugs used

Event ID DRUG SEQ INDI PT
6818809 1014042638 URINARY INCONTINENCE

Outcome of event

Event ID OUTC COD
6818809 OT

Reactions reported

Event ID PT
6818809 DEPRESSION
6818809 SUICIDAL IDEATION

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
6818809 FGN
6818809 HP
6818809 OTH

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6818809 1014042638 20090701